Spontaneous lung and lymph node metastasis in transgenic breast cancer is independent of the urokinase receptor uPAR.

about

D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR.Silencing of uPAR via RNA interference inhibits invasion and migration of oral tongue squamous cell carcinoma

P2860

Q48220228-7238F5A2-B795-4C1C-B906-1C2C3ACA7CFF Q57165696-E678E318-7F67-4AD2-A00A-E485334D63FD

P2860

Spontaneous lung and lymph node metastasis in transgenic breast cancer is independent of the urokinase receptor uPAR.

Item

http://www.wikidata.org/entity/Q40872425

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Spontaneous lung and lymph nod ...... f the urokinase receptor uPAR.

@en

type

Item

label

Spontaneous lung and lymph nod ...... f the urokinase receptor uPAR.

@en

prefLabel

Spontaneous lung and lymph nod ...... f the urokinase receptor uPAR.

@en

P1476

Spontaneous lung and lymph nod ...... f the urokinase receptor uPAR.

@en

P2093

Annika Jögi

http://www.w3.org/2001/XMLSchema#string

Boye Schnack Nielsen

http://www.w3.org/2001/XMLSchema#string

Ida Katrine Lund

http://www.w3.org/2001/XMLSchema#string

John Rømer

http://www.w3.org/2001/XMLSchema#string

Kasper Almholt

http://www.w3.org/2001/XMLSchema#string

Leif Røge Lund

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide

RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo

The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies

The urokinase plasminogen activator receptor in the regulation of the actin cytoskeleton and cell motility

Neutralisation of uPA with a monoclonal antibody reduces plasmin formation and delays skin wound healing in tPA-deficient mice

Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy

Simplified mammalian DNA isolation procedure

Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease

Extracellular alpha 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancer

Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases.

P2888

s10585-015-9726-1

P304

543-554

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10585-015-9726-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ole Didrik Lærum

P577

2015-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1002861179

http://www.w3.org/2001/XMLSchema#string

P698

26040548

http://www.w3.org/2001/XMLSchema#string

Spontaneous lung and lymph node metastasis in transgenic breast cancer is independent of the urokinase receptor uPAR.

about

P2860

P2860

Spontaneous lung and lymph node metastasis in transgenic breast cancer is independent of the urokinase receptor uPAR.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698